NYSE:ATAC

Altimar Acquisition Competitors

$9.99
+0.03 (+0.30 %)
(As of 04/14/2021 04:54 PM ET)
Add
Compare
Today's Range
$9.92
Now: $9.99
$9.99
50-Day Range
$9.74
MA: $10.06
$10.72
52-Week Range
$9.64
Now: $9.99
$12.07
Volume261,656 shs
Average Volume630,694 shs
Market Capitalization$343.41 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

Altimar Acquisition (NYSE:ATAC) Vs. AJAX, AJAX, BTWN, CMLF, BOAC, and BOWX

Should you be buying ATAC stock or one of its competitors? Companies in the industry of "shell companies" are considered alternatives and competitors to Altimar Acquisition, including Ajax I (AJAX), Ajax I (AJAX), Bridgetown (BTWN), CM Life Sciences (CMLF), Bluescape Opportunities Acquisition (BOAC), and BowX Acquisition (BOWX).

Ajax I (NYSE:AJAX) and Altimar Acquisition (NYSE:ATAC) are both small-cap unclassified companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, risk, institutional ownership, earnings, dividends, analyst recommendations and valuation.

Analyst Ratings

This is a summary of current recommendations and price targets for Ajax I and Altimar Acquisition, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Ajax I0000N/A
Altimar Acquisition0000N/A

Profitability

This table compares Ajax I and Altimar Acquisition's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Ajax IN/AN/AN/A
Altimar AcquisitionN/AN/AN/A

Valuation and Earnings

This table compares Ajax I and Altimar Acquisition's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ajax IN/AN/AN/AN/AN/A
Altimar AcquisitionN/AN/AN/AN/AN/A

Altimar Acquisition (NYSE:ATAC) and Ajax I (NYSE:AJAX) are both small-cap unclassified companies, but which is the better business? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, profitability, valuation, analyst recommendations and dividends.

Analyst Recommendations

This is a breakdown of recent ratings for Altimar Acquisition and Ajax I, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Altimar Acquisition0000N/A
Ajax I0000N/A

Profitability

This table compares Altimar Acquisition and Ajax I's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Altimar AcquisitionN/AN/AN/A
Ajax IN/AN/AN/A

Earnings and Valuation

This table compares Altimar Acquisition and Ajax I's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Altimar AcquisitionN/AN/AN/AN/AN/A
Ajax IN/AN/AN/AN/AN/A

Bridgetown (NASDAQ:BTWN) and Altimar Acquisition (NYSE:ATAC) are both small-cap unclassified companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, valuation, profitability, analyst recommendations, institutional ownership, risk and dividends.

Profitability

This table compares Bridgetown and Altimar Acquisition's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
BridgetownN/AN/AN/A
Altimar AcquisitionN/AN/AN/A

Analyst Recommendations

This is a summary of current recommendations for Bridgetown and Altimar Acquisition, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Bridgetown0000N/A
Altimar Acquisition0000N/A

Valuation & Earnings

This table compares Bridgetown and Altimar Acquisition's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BridgetownN/AN/AN/AN/AN/A
Altimar AcquisitionN/AN/AN/AN/AN/A

CM Life Sciences (NASDAQ:CMLF) and Altimar Acquisition (NYSE:ATAC) are both small-cap financial services companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, valuation, dividends, risk, profitability, analyst recommendations and institutional ownership.

Valuation & Earnings

This table compares CM Life Sciences and Altimar Acquisition's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CM Life SciencesN/AN/AN/AN/AN/A
Altimar AcquisitionN/AN/AN/AN/AN/A

Profitability

This table compares CM Life Sciences and Altimar Acquisition's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
CM Life SciencesN/AN/AN/A
Altimar AcquisitionN/AN/AN/A

Analyst Recommendations

This is a summary of recent ratings and recommmendations for CM Life Sciences and Altimar Acquisition, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
CM Life Sciences0000N/A
Altimar Acquisition0000N/A

Altimar Acquisition (NYSE:ATAC) and Bluescape Opportunities Acquisition (NYSE:BOAC) are both small-cap unclassified companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, profitability, earnings, institutional ownership and dividends.

Profitability

This table compares Altimar Acquisition and Bluescape Opportunities Acquisition's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Altimar AcquisitionN/AN/AN/A
Bluescape Opportunities AcquisitionN/AN/AN/A

Earnings & Valuation

This table compares Altimar Acquisition and Bluescape Opportunities Acquisition's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Altimar AcquisitionN/AN/AN/AN/AN/A
Bluescape Opportunities AcquisitionN/AN/AN/AN/AN/A

Analyst Ratings

This is a summary of current ratings and price targets for Altimar Acquisition and Bluescape Opportunities Acquisition, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Altimar Acquisition0000N/A
Bluescape Opportunities Acquisition0000N/A

BowX Acquisition (NASDAQ:BOWX) and Altimar Acquisition (NYSE:ATAC) are both small-cap unclassified companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, profitability, earnings, dividends, valuation, risk and institutional ownership.

Analyst Recommendations

This is a breakdown of recent ratings and target prices for BowX Acquisition and Altimar Acquisition, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
BowX Acquisition0000N/A
Altimar Acquisition0000N/A

Profitability

This table compares BowX Acquisition and Altimar Acquisition's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
BowX AcquisitionN/AN/AN/A
Altimar AcquisitionN/AN/AN/A

Valuation and Earnings

This table compares BowX Acquisition and Altimar Acquisition's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BowX AcquisitionN/AN/AN/AN/AN/A
Altimar AcquisitionN/AN/AN/AN/AN/A


Altimar Acquisition Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
Ajax I logo
AJAX
Ajax I
0.0$10.11+0.3%$904.27 millionN/A0.00Increase in Short Interest
Ajax I logo
AJAX
Ajax I
0.0$10.11+0.3%$904.27 millionN/A0.00Increase in Short Interest
BTWN
Bridgetown
0.0$10.68+1.3%$794.31 millionN/A0.00
CMLF
CM Life Sciences
0.0$13.98+2.8%$773.71 millionN/A0.00
BOAC
Bluescape Opportunities Acquisition
0.0$10.11+0.9%$767.73 millionN/A0.00Decrease in Short Interest
BOWX
BowX Acquisition
0.0$12.45+8.8%$751.67 millionN/A0.00Increase in Short Interest
VYGG
Vy Global Growth
0.0$10.38+0.4%$743.19 millionN/A0.00
TPGY
TPG Pace Beneficial Finance
0.3$16.06+5.5%$702.63 millionN/A0.00
HZON
Horizon Acquisition Co. II
0.0$10.22+0.9%$677.53 millionN/A0.00
LCY
Landcadia Holdings III
1.7$10.42+0.2%$670.79 millionN/A0.00News Coverage
ACIC
Atlas Crest Investment
0.0$10.01+0.5%$625.63 millionN/A0.00
MIT
Mason Industrial Technology
0.0$9.85+0.2%$615.63 millionN/A0.00News Coverage
VSPR
Vesper Healthcare Acquisition
1.7$10.55+0.8%$606.63 millionN/A0.00Analyst Report
Decrease in Short Interest
HAAC
Health Assurance Acquisition
0.0$10.67+1.4%$590.85 millionN/A0.00
KVSC
Khosla Ventures Acquisition Co. III
0.0$10.15+0.0%$571.16 millionN/A0.00
VAQC
Vector Acquisition Corp II
0.0$10.00+0.5%$570.63 millionN/A0.00Quiet Period Expiration
TPG Pace Tech Opportunities logo
PACE
TPG Pace Tech Opportunities
0.0$10.05+0.0%$565.31 millionN/A0.00
CFII
CF Finance Acquisition Corp. II
0.3$8.39+2.5%$533.60 millionN/A0.00Increase in Short Interest
News Coverage
MUDS
Mudrick Capital Acquisition Co. II
0.0$13.24+0.9%$523.39 millionN/A0.00Unusual Options Activity
MAAC
Montes Archimedes Acquisition
0.0$9.92+0.7%$517.57 millionN/A0.00
MOTV
Motive Capital
0.0$9.92+0.6%$516.47 millionN/A0.00
SNRH
Senior Connect Acquisition Corp. I
0.0$9.86+0.7%$513.88 millionN/A0.00News Coverage
DGNU
ArcLight Clean Transition Corp. II Unit
0.0$10.20+0.4%$508 millionN/A0.00
CTAQ
Carney Technology Acquisition Corp. II
0.0$9.90+0.6%$507.01 millionN/A0.00
IIAC
Investindustrial Acquisition
0.0$9.99+0.3%$502.63 millionN/A0.00
SPNV
Supernova Partners Acquisition
0.0$9.99+0.2%$502.63 millionN/A0.00Increase in Short Interest
GMII
Gores Metropoulos II
0.0$10.01+0.3%$500.50 millionN/A0.00
EPHY
Epiphany Technology Acquisition
0.0$9.83+0.6%$499.36 millionN/A0.00
AGCB
Altimeter Growth Corp. 2
0.0$11.03+0.2%$495.45 millionN/A0.00News Coverage
KVSB
Khosla Ventures Acquisition Co. II
0.0$10.24+0.4%$470.22 millionN/A0.00
NGAC
NextGen Acquisition
0.0$10.00+0.1%$469.22 millionN/A0.00Increase in Short Interest
News Coverage
SPFR
Jaws Spitfire Acquisition
0.0$10.69+0.1%$461.01 millionN/A0.00
HIGA
H.I.G. Acquisition
0.0$9.98+0.2%$456.47 millionN/A0.00Decrease in Short Interest
GHVI
Gores Holdings VI
0.0$12.96+0.5%$447.12 millionN/A0.00News Coverage
Gap Down
LUXA
Lux Health Tech Acquisition
0.0$10.31+0.8%$441.17 millionN/A0.00Decrease in Short Interest
FSRV
FinServ Acquisition
0.0$13.67+1.3%$436.28 millionN/A0.00
CAP
Capitol Investment Corp. V
0.0$9.98+0.6%$430.39 millionN/A0.00
RMGB
RMG Acquisition Co. II
0.0$9.97+0.0%$429.96 millionN/A0.00News Coverage
GFX
Golden Falcon Acquisition
0.0$9.89+0.6%$423.92 millionN/A0.00
PCPC
Periphas Capital Partnering
0.0$24.68+0.7%$414.69 millionN/A0.00
PIAI
Prime Impact Acquisition I
0.0$9.92+0.2%$401.87 millionN/A0.00Decrease in Short Interest
NSTB
Northern Star Investment Corp. II
0.0$9.98+0.3%$400.40 millionN/A0.00
HOL
Holicity
0.0$10.57+3.1%$396.38 millionN/A0.00Increase in Short Interest
News Coverage
RAAC
Revolution Acceleration Acquisition
0.0$10.20+0.1%$391.00 millionN/A0.00
TSIA
TS Innovation Acquisitions
0.0$10.30+1.4%$386.25 millionN/A0.00Increase in Short Interest
XPOA
DPCM Capital
0.0$9.98+0.3%$385.48 millionN/A0.00Increase in Short Interest
KVSA
Khosla Ventures Acquisition
0.0$10.57+0.2%$379.46 millionN/A0.00Quiet Period Expiration
IGAC
IG Acquisition
0.0$10.00+0.4%$375 millionN/A0.00Decrease in Short Interest
PRSR
Prospector Capital
0.0$9.87+0.2%$370.13 millionN/A0.00
GMBT
Queen's Gambit Growth Capital
0.0$9.85+0.0%$369.38 millionN/A0.00
This page was last updated on 4/14/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.